© All rights reserved.
REBOA has been around since the 1950's, when first used by American Lt. Col. Carl W. Hughes during the Korean War. Although it's used globally for the management of severe non-compressible torso haemorrhage, the evidence base to date doesn't support such widespread adoption. Is it beneficial? Is it harmful? Join us at the Critical Care Reviews Meeting 2023 to hear the results of the first randomised controlled trial investigating this device - the UK REBOA Trial.
added March 21st
We follow the critical care literature daily so you don't have to. Either keep track of our Journal Watch webpage or register for our free weekly newsletter, containing links to all the papers posted in our journal watch resource over the previous week. There's nothing else like it.
Registration for the Critical Care Reviews Meeting 2023 opens on Monday, October 17th at 19:00 UTC+1. The meeting is being held in Titanic Belfast, Belfast, Northern Ireland. This niche meeting hosts major critical care trial results, reviews the best trials of the preceding 12 months and discusses all aspects of trial methodology, design, interpretation and publishing.